EUVIMEDEUVIMED entdecken
Crossref

Hereditary Spherocytosis: A Case Series Spanning Prenatal Detection to Neonatal Care

Carly M Smith iD, Alexandra M Dinu, Susan R Hintz, Kathleen C Minor, Kristine Foley, Nicole Weigel, Bertil E Glader, Yair J Blumenfeld

Prenatal Diagnosis · 23.05.2026

DOI: 10.1002/pd.70185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 23.05.2026. Verfasst von Carly M Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fetal and Pregnancy Health Program, Stanford Medicine Children's Health, Palo Alto, California, USA. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aim to expand the prenatal phenotypic spectrum of hereditary spherocytosis (HS).

Method

We reviewed four pregnancies at risk for or suspected of having HS. Prenatal ultrasound, middle cerebral artery (MCA) Doppler surveillance, genetic testing, and neonatal outcomes were evaluated.

Results

Case 1 involved a fetus with a homozygous variant in SPTA1 with severe fetal anemia and nonimmune hydrops fetalis resulting in fetal demise. Case 2 involved a mother with a heterozygous ANK1 variant. Fetal anemia and polyhydramnios prompted close prenatal surveillance, and the infant required four red cell transfusions. The mother of Case 3 had a heterozygous SPTB variant. Although fetal surveillance was reassuring, the neonate required quintuple phototherapy. Case 4 involved a mother with a heterozygous SPTB variant and a family history of neonatal bilirubin toxicity. Fetal surveillance was unremarkable, and the neonate had no hematologic complications.

Conclusions

This series illustrates the diverse courses of pregnancies at risk of HS. While MCA Doppler ultrasound is a valuable surveillance tool to identify fetal anemia, our findings suggest that MCA Doppler values alone may not reliably predict postnatal severity. In pregnancies at risk of HS, consideration of maternal and family history, genetic evaluation, and serial surveillance remains essential for prenatal counseling and perinatal planning.

Schlagwörter

Stichwörter der Autor:innen

ANK1MCA DopplerSPTA1SPTBhereditary spherocytosis

Autor:innen und Institutionen

  • Fetal and Pregnancy Health Program, Stanford Medicine Children's Health, Palo Alto, California, USA.
  • Department of Pediatrics, Division of Medical Genetics, Stanford University School of Medicine, Stanford, California, USA.
  • College of Osteopathic Medicine, Pacific Northwest University of Health Sciences, Yakima, Washington, USA.
  • Department of Pediatrics, Division of Neonatology and Developmental Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine and Obstetrics, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pediatrics, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Carly M Smith

Zitieren

APA

Smith, C. M., Dinu, A. M., Hintz, S. R., Minor, K. C., Foley, K., Weigel, N., Glader, B. E., & Blumenfeld, Y. J. (2026). Hereditary Spherocytosis: A Case Series Spanning Prenatal Detection to Neonatal Care. Prenatal Diagnosis. https://doi.org/10.1002/pd.70185

Vancouver

Smith CM, Dinu AM, Hintz SR, Minor KC, Foley K, Weigel N, et al. Hereditary Spherocytosis: A Case Series Spanning Prenatal Detection to Neonatal Care. Prenatal Diagnosis. 2026. doi:10.1002/pd.70185

BibTeX
@article{Smith2026,
  author = {Smith, Carly M and Dinu, Alexandra M and Hintz, Susan R and Minor, Kathleen C and Foley, Kristine and Weigel, Nicole and Glader, Bertil E and Blumenfeld, Yair J},
  title = {Hereditary Spherocytosis: A Case Series Spanning Prenatal Detection to Neonatal Care},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70185}
}
Kostenlos starten →